Cigna is a US healthcare company. Through its Evernorth division with Express Scripts it manages pharmacy benefits and runs mail-order and specialty pharmacies. It also provides health insurance for employers in the US and international health plans. As of Oct 11, 2026
As of Oct 11, 2026Fact sheet (from the annual report)Health insurance and health plans · Bloomfield, USAfull fact sheet
According to the company, The Cigna Group is a global health company with health insurance and pharmacy services. The Evernorth Health Services area comprises the segments for pharmacy benefit services and for specialty and care services. These include pharmacy claims processing, management of pharmacy networks and the specialty pharmacy Accredo. Customers of this area include health insurers, employers, union plans and government health programs, among others. The Cigna Healthcare segment offers health insurance for employers, individuals and globally mobile customers. The group divested its Medicare Advantage business in 2025.
Our own calculation from the exchange’s daily candles, as of Oct 26, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.
52-week-high breakout · Analysis method
The price of CI is currently in no zone of this method. The check runs daily after the market close.
Whether a price will soon reach a zone, you see from Watcher. Plans and pricing
How the zone is formed
What is this? The price closes above the highest high of the last 52 weeks for the first time, on clearly higher volume. New 52-week highs are seen as a sign of strength.
Buy zone: the old high up to 1 ATR above it (retest). Stop: 1.5 ATR below the old high. Targets: 3 and 5 ATR above the old high.
The pattern is valid for at most 15 trading days and expires if the price falls below the stop. This is a calculated analysis, not a forecast and not a call to buy. Risk notice and investment advice
Load chart from TradingView
This transfers data (including your IP address) to TradingView, also to the USA. More in the Privacy policy.
SEC filing (10-K, 10-Q)Required reports of listed companies to the US Securities and Exchange Commission (SEC): 10-K is the annual report, 10-Q the quarterly report, 20-F the annual report of foreign companies. We show the figures of the first filing.Example: 10-K for the fiscal year ending Sep 27, 2025, filed on Oct 31, 2025.More in the Academy: Lesson revenue, profit and margin
Cigna · Sector Health Care · amounts in USD
Information only – does not affect our buy zones, not investment advice. Source: SEC filings, As of Feb 26, 2026.
In short
Light green: Revenue grew over 5 years (+11.4% per year), at least as fast as the sector median.
Light red: Net income (total) shrank over 5 years (−6.8% per year); per share −0.7% per year.
Light yellow: Net margin 2.2%, below the sector median (12.9%).
Light green: Profit in each of the last 10 fiscal years.
Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.
RevenueNet incomeNet margin (below)in USD
0100B200B300B
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Revenue 39.8B USD · Net income 1.8B USD · Net margin 4.6%
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Revenue 41.8B USD · Net income 2.2B USD · Net margin 5.3%
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Revenue 48.7B USD · Net income 2.6B USD · Net margin 5.4%
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 153.6B USD · Net income 5.1B USD · Net margin 3.3%
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 160.4B USD · Net income 8.5B USD · Net margin 5.3%
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 174.1B USD · Net income 5.4B USD · Net margin 3.1%
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 180.5B USD · Net income 6.7B USD · Net margin 3.7%
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 195.3B USD · Net income 5.2B USD · Net margin 2.6%
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 247.1B USD · Net income 3.4B USD · Net margin 1.4%
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 274.9B USD · Net income 6.0B USD · Net margin 2.2%
Margin
5%5%5%3%5%3%4%3%1%2%
RevenueNet incomeNet margin (below)in USD
−20B020B40B60B80B
Q3/23Quarter Q3/23 (Jul 1, 2023 – Sep 30, 2023): Revenue 49.0B USD · Net income 1.4B USD · Net margin 3.0%
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Revenue 51.1B USD · Net income not available · Net margin not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Revenue 57.3B USD · Net income −212.0M USD · Net margin −0.4%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Revenue 60.5B USD · Net income 1.6B USD · Net margin 2.7%
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Revenue 63.7B USD · Net income 825.0M USD · Net margin 1.3%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Revenue 65.6B USD · Net income not available · Net margin not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Revenue 65.5B USD · Net income 1.3B USD · Net margin 2.0%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Revenue 67.2B USD · Net income 1.5B USD · Net margin 2.3%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Revenue 69.7B USD · Net income 2.0B USD · Net margin 2.8%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Revenue 72.5B USD · Net income not available · Net margin not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Revenue 68.5B USD · Net income 1.7B USD · Net margin 2.4%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Revenue 71.7B USD · Net income 1.7B USD · Net margin 2.3%
Margin
3%−0%3%1%2%2%3%2%2%
Earnings per shareUSD per share
0102030
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Earnings per share 7.19 USD
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Earnings per share 8.77 USD
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Earnings per share 10.54 USD
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Earnings per share 13.44 USD
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Earnings per share 22.96 USD
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Earnings per share 15.73 USD
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Earnings per share 21.30 USD
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Earnings per share 17.39 USD
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Earnings per share 12.12 USD
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Earnings per share 22.18 USD
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Earnings per share not reported separately for Q4
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Earnings per share 6.26 USD
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Earnings per share 6.29 USD
Dividend per sharePayout ratio (below)USD per share
02.004.006.008.00
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Dividend per share not available · Payout ratio not available
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Dividend per share 0.04 USD · Payout ratio 0.5%
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Dividend per share 0.04 USD · Payout ratio 0.4%
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Dividend per share 0.04 USD · Payout ratio 0.3%
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Dividend per share 0.04 USD · Payout ratio 0.2%
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Dividend per share 4.00 USD · Payout ratio 25.4%
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Dividend per share 4.48 USD · Payout ratio 21.0%
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Dividend per share 4.92 USD · Payout ratio 28.3%
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Dividend per share 5.60 USD · Payout ratio 46.2%
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Dividend per share 6.04 USD · Payout ratio 27.2%
Ratio
0%0%0%0%25%21%28%46%27%
Dividend per sharePayout ratio (below)USD per share
00.501.001.502.00
Q3/23Quarter Q3/23 (Jul 1, 2023 – Sep 30, 2023): Dividend per share 1.23 USD · Payout ratio 25.9%
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Dividend per share 1.23 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Dividend per share 1.40 USD · Payout ratio not available
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Dividend per share 1.40 USD · Payout ratio 25.7%
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Dividend per share 1.40 USD · Payout ratio 53.2%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Dividend per share 1.40 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Dividend per share 1.51 USD · Payout ratio 31.1%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Dividend per share 1.51 USD · Payout ratio 26.4%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Dividend per share 1.51 USD · Payout ratio 21.6%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Dividend per share 1.51 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Dividend per share 1.56 USD · Payout ratio 24.9%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Dividend per share 1.56 USD · Payout ratio 24.8%
Ratio
26%26%53%31%26%22%25%25%
Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 274.9B USD · Net income 6.0B USD · Net margin 2.2%
Key figures with traffic lights
Each light follows a simple, disclosed rule. The comparison is with the sector median Sector medianThe middle value of all companies in a sector: half are above it, half below. Unlike the average, single outliers hardly distort it.Example: Margins 4%, 8%, 10%, 12%, 60% → median 10%, average 18.8%.More in the Academy: Lesson putting the P/E in context of all 63 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).
Revenue growth
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light green: above sector
+11.4%per year, last 5 years
Sector Health Care: median +7.8% (60 symbols)
What does this mean? Revenue: over 5 years it grew by 11.4% per year on average – at least as fast as the median company in the sector (+7.8%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
Net income (total)
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light red: shrinking
−6.8%per year, last 5 years
Sector Health Care: median +7.5% (46 symbols)
per share: −0.7% per year (5 years, split-adjusted)
What does this mean? Total net income: over 5 years it fell by 6.8% per year on average. The median company in the sector reached +7.5% per year.
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
What does this mean? Of every 100 USD in revenue, 2.17 USD remained as profit – less than the median company in the sector (12.9%). Five years ago the margin was 5.3%.
Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.
Debt / equity
Debt-to-equity ratioFinancial debt (loans, bonds) divided by equity. A high value amplifies good and bad years alike. The key figures bar in the chart only uses long-term financial debt.Example: Financial debt €300m, equity €500m → 0.6.More in the Academy: Lesson debt, dividends and growth
Light gray: not available
–latest balance sheet
Sector Health Care: median 0.66 (40 symbols)
What does this mean? No usable figure: reported financial debt or positive equity for the same balance sheet date is missing.
Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.
Payout ratio
Payout ratioThe share of profit that a company pays out as a dividend. Above 100% it pays out more than it earns.Example: Dividend €1, earnings per share €2.50 → payout ratio 40%.More in the Academy: Lesson debt, dividends and growth
Light green: covered
27%Dividend / earnings per share
Sector Health Care: median 28% (31 symbols)
What does this mean? Of every 1 USD of earnings per share, 0.27 USD went to shareholders as a dividend. The rest stays in the company. Median company in the sector: 28%.
Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.
Profitable years
Profitable yearsHow many of the last fiscal years ended with a profit rather than a loss on the bottom line. The figure shows how consistently a company earns.Example: Profit in 9 of 10 years → one loss year.More in the Academy: Lesson revenue, profit and margin
Light green: profit every year
10 of 10fiscal years with a profit
What does this mean? In 10 of the last 10 fiscal years the bottom line showed a profit. There were no losses in this period.
Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).
Last fiscal year and 13F
Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
274.9B USD
Revenue vs. prior year
+11.2%
Net income (FY)
6.0B USD
Net income vs. prior year
+73.5%
EPS (FY)
22.18 USD
13F funds with a position
1 of 9
Funds vs. prior quarter
±0
Shares held vs. prior quarter
+219.2%
Fiscal year to Dec 31, 2025 · 10-K filed Feb 26, 2026 · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term).13F: reporting date Jun 30, 2026, 9 tracked funds have filed (latest Aug 14, 2026), filed with up to 45 days of delay. Stock positions only; comparison with Mar 31, 2026 only across funds that filed for both quarters.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
Year
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
2025
Dec 31, 2025
274.9B
6.0B
2.2%
22.18
6.04
27%
2024
Dec 31, 2024
247.1B
3.4B
1.4%
12.12
5.60
46%
2023
Dec 31, 2023
195.3B
5.2B
2.6%
17.39
4.92
28%
2022
Dec 31, 2022
180.5B
6.7B
3.7%
21.30
4.48
21%
2021
Dec 31, 2021
174.1B
5.4B
3.1%
15.73
4.00
25%
2020
Dec 31, 2020
160.4B
8.5B
5.3%
22.96
0.04
0%
2019
Dec 31, 2019
153.6B
5.1B
3.3%
13.44
0.04
0%
2018
Dec 31, 2018
48.7B
2.6B
5.4%
10.54
0.04
0%
2017
Dec 31, 2017
41.8B
2.2B
5.3%
8.77
0.04
0%
2016
Dec 31, 2016
39.8B
1.8B
4.6%
7.19
–
–
Quarters (amounts in USD, per share in USD)
Quarter
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
Q2/26
Jun 30, 2026
71.7B
1.7B
2.3%
6.29
1.56
25%
Q1/26
Mar 31, 2026
68.5B
1.7B
2.4%
6.26
1.56
25%
Q4/25*
Dec 31, 2025
72.5B
–
–
–
1.51
–
Q3/25
Sep 30, 2025
69.7B
2.0B
2.8%
6.98
1.51
22%
Q2/25
Jun 30, 2025
67.2B
1.5B
2.3%
5.71
1.51
26%
Q1/25
Mar 31, 2025
65.5B
1.3B
2.0%
4.85
1.51
31%
Q4/24*
Dec 31, 2024
65.6B
–
–
–
1.40
–
Q3/24
Sep 30, 2024
63.7B
825.0M
1.3%
2.63
1.40
53%
Q2/24
Jun 30, 2024
60.5B
1.6B
2.7%
5.45
1.40
26%
Q1/24
Mar 31, 2024
57.3B
−212.0M
−0.4%
−0.97
1.40
–
Q4/23*
Dec 31, 2023
51.1B
–
–
–
1.23
–
Q3/23
Sep 30, 2023
49.0B
1.4B
3.0%
4.74
1.23
26%
* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.
How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.
Insiders
Insider transactionsExecutives, directors and major shareholders (over 10%) of US companies report their own transactions in their company’s stock to the SEC within two business days (Form 4). Purchases in the market count as more meaningful than sales (often taxes, estate planning).Example: Three executives acquire stock worth a total of 2 million USD within two weeks → “purchases by several insiders”.More in the Academy: Glossary
May 12, 2026Cordani DavidChief executive (CEO), DirectorOpen-market sale · 10b5-1 plan2,231 shares · $666.0K · SEC
May 12, 2026Cordani DavidChief executive (CEO), DirectorOpen-market sale · 10b5-1 plan15,319 shares · $4.6M · SEC
Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.
Trend score +70
Price vs. EMA 50+15
Price vs. EMA 200+15
EMA 50 vs. EMA 200+20
ADX (trend strength)+15
Highs and lows-10
Relative strength+15
Volatility and trend strength
ADX 14 (trend strength)26.5
Rel. strength 60 d+7.0%
ATR ATR (Average True Range)The average range per trading day over the last 14 days. It makes distances comparable, whether a stock costs 10 or 1,000.Example: ATR 2.50 at a price of 100: 0.4 ATR is 1.00, i.e. 1%.More in the Academy: Lesson ATR and moving averages as price values only when logged in.